Posted on 288
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has agreed with Worldpharma Biotech (“Worldpharma”), through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. (“Tilray Portugal”), to export Good Manufacturing Processes (GMP) certified medical cannabis from Portugal to Spain. The shipment marks the first medical cannabis import into Spain by Worldpharma and the 17
th country to receive Tilray medical cannabis worldwide.
The Agencia Española de Medicamentos y Productos Sanitorios (AEMPS), Spain’s food and drug administration, has approved Worldpharma to import Tilray’s GMP-certified medical cannabis as raw material from its Portugal facility to Spain. With Tilray’s pharmaceutical-grade cannabis, Worldpharma will develop medical cannabis products for clinical trials in Spanish Hospitals for diseases suc
Tilray, Inc.: Tilray Exports First Shipment of Medical Cannabis to Spain
Tilray medical cannabis will now be available in 17 countries around the world
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has agreed with Worldpharma Biotech ( Worldpharma ), through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. ( Tilray Portugal ), to export Good Manufacturing Processes (GMP) certified medical cannabis from Portugal to Spain. The shipment marks the first medical cannabis import into Spain by Worldpharma and the 17
th country to receive Tilray medical cannabis worldwide.
The Agencia Española de Medicamentos y Productos Sanitorios (AEMPS), Spain s food and drug administration, has approved Worldpharma to import Tilray s GMP-certified medical cannabis as raw material from its Portugal facility to Spain. With Tilray s pharmaceutical-grade cannabis, Worldpharma will develop medical cannabis pro